lead position
Trademarks
Loke Khoon Tan and Stephanie Yip at Dentons explain what brand owners need to know ahead of January 1 2027, when updates to China’s Trade Mark Law come into force
August 7, 2026
Features list
-
In the latest in our series of UPC scenarios, Laura Whiting and Inmaculada Lorenzo explore the options for a pharmaceutical patent owner faced with a potential infringer manufacturing its product in Spain -
Genomic technology has rapidly created a multi-billion dollar growth industry. With life sciences companies scrambling in US and European courts for a share of the lucrative market, in-house IP counsel should start preparing for the next wave of IP litigation, explain Dominic Adair and Annsley Merelle Ward
-
The past two years have seen some fundamental changes to patent, utility model and design law in Russia. Eugene Arievich and Yuri Pylnev review how they are working in practice
-
For many years there has been debate about EPO practice relating to amendments under Article 123(2) EPC in examination and opposition proceedings. Charlotta Vink and Louise Tottie of Valea examine the latest cases
-
As the European Commission aspires to introduce a Unitary SPC, Tony Rollins examines the evidence on how effective the existing regime for patent extension in Europe has been
-
What trade mark issues arise with the resurrection of zombie brands? Carrie Bradley and Tony Dylan-Hyde examine the position in Europe and the United States
Local Insights
Sponsored by
Vivien Chan & Co
Anna Mae Koo and Owen Tse of Vivien Chan & Co examine how trademarks, personality rights, and AI regulations can help celebrities and influencers combat deepfake impersonation in China
Sponsored by
Liu Shen & Associates
Ke Mou and Stephen Zou of Liu Shen & Associates outline China’s evolving framework on pharmaceutical intellectual property protection, examining how data exclusivity, patent term extension, patent linkage, and enforcement mechanisms support innovation
Sponsored by
Gün + Partners
Selin Sinem Erciyas of Gün + Partners examines whether the EU Pharma Package’s expanded Bolar exemption aligns with the TRIPS Agreement, drawing lessons from Türkiye’s long-standing pharmaceutical patent jurisprudence
Sponsored by
HANOL ClassHankyul IP & Law
A recent case establishes that commercial considerations outweigh genus or species factors when assessing similarity between goods designated in trademark applications and protected crop varieties, says Min Son of HANOL ClassHankyul IP & Law
Sponsored by
INLEX
Igor Charles and Théo Coquis of INLEX analyse a Paris Judicial Court ruling confirming that trademark exhaustion applies to bundled genuine products where the original packaging remains unaltered
Sponsored by
Inventa
Vera Albino of Inventa explores how Portuguese wine producers use seemingly offensive names rooted in local history and folklore, and why trademark law often permits their registration
Sponsored by
Inspicos
Peter Koefoed of Inspicos examines how the EPO Enlarged Board of Appeal referral G 1/26 could clarify the application of G 1/24 when assessing the allowability of amended patent claims under the EPC
Sponsored by
RNA, Technology and IP Attorneys
Ranjan Narula and Eeshani Sharma of RNA, Technology and IP Attorneys examine how the Exide v Amara Raja dispute confirms Indian courts’ willingness to protect distinctive product get-up and restrain lookalike packaging
Sponsored by
Saint Island International Patent & Law Offices
Amanda Y S Liu of Saint Island International Patent & Law Offices examines a ruling that clarifies the boundaries of when well-known trademarks can secure cross-class protection despite strong consumer recognition
Sponsored by
Tilleke & Gibbins
The new legislation signals a shift towards proactive platform responsibility and infringement prevention, write Linh Duy Mai and Diep Thi Bich Le of T&G Law Firm LLC (TGVN), the local associate of Tilleke & Gibbins